Primary Care Diabetes

Papers
(The H4-Index of Primary Care Diabetes is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people72
Obesity and risk of COVID-19: analysis of UK biobank65
Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: A systematic review and meta-analysis of cohort studies62
Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-1961
Insulin resistance in COVID-19 and diabetes60
Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study54
Diabetes and COVID-19: A pooled analysis related to disease severity and mortality52
A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes51
The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study49
Challenges of routine diabetes care during COVID-19 era: A systematic search and narrative review41
Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis40
Review: Type 2 diabetes in Latin America and the Caribbean: Regional and country comparison on prevalence, trends, costs and expanded prevention38
A review on current advances in machine learning based diabetes prediction36
Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis36
COVID-19 and diabetes: What does the clinician need to know?34
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis30
Newly diagnosed diabetes in COVID-19 patients29
Comparison of the effects of 10 GLP-1 RA and SGLT2 inhibitor interventions on cardiovascular, mortality, and kidney outcomes in type 2 diabetes: A network meta-analysis of large randomized trials29
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study28
Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?27
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe26
Prevalence of type 2 diabetes in Middle–East: Systematic review& meta-analysis26
Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic26
Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review26
Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study25
0.053933143615723